nexpovio
stemline therapeutics b.v. - selinexor - Πολλαπλό μυέλωμα - Αντινεοπλασματικοί παράγοντες - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
nexpovio f.c.tab 20mg/tab
selinexor - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 20mg/tab - selinexor 20mg - selinexor
xpovio f.c.tab 20mg/tab
selinexor - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 20mg/tab - selinexor 20mg - selinexor